gdc
Thyroid Cancer

Drugs for Thyroid Cancer

Here are the financial support services available to patients receiving treatment for Thyroid Cancer.

Armour Thyroid (thyroid tablets, USP)

Drug company: Allergan
844-424-6727

Armour Thyroid tablets are pituitary thyroid-stimulating hormone suppressants used for the treatment of patients with thyroid cancer.

Allergen offers 1 financial assistance program for patients using Armour Thyroid:

Allergan Patient Assistance Program

Patients who are unable to afford the cost of Armour Thyroid tablets and meet other eligibility requirements are eligible for free medication. Eligible applicants will be enrolled for 12 months and a 90-day supply of medication will be shipped immediately to the physician. Medicare Part D applicants must have been denied the Low Income Subsidy and will only be enrolled until the end of the calendar year.

Caprelsa (vandetanib) Tablets

Drug company: Sanofi Genzyme
800-367-4999

Caprelsa is a kinase inhibitor used for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced or metastatic disease.

Caprelsa Access Support offers 3 financial assistance programs for patients using Caprelsa:

Caprelsa Co-Pay Assistance Program

Patients with private insurance whose out-of-pocket costs associated with Caprelsa are more than $50 may be eligible for assistance of up to $20,000 annually through this program.

Caprelsa Interim Access Program

This program provides a short-term supply of Caprelsa free of charge to patients with private insurance who are experiencing a delay in receiving coverage for this medication.

Sanofi Genzyme Patient Assistance Program

For eligible patients who are uninsured or underinsured, this program may provide Caprelsa free of charge.

Cometriq (cabozantinib)

Drug company: Exelixis
855-253-3273

Cometriq is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer.

Exelixis offers 2 financial assistance programs for patients using Cometriq:

Exelixis Access Services Co-pay Assistance Program

This program helps with out-of-pocket costs for patients who have private insurance and meet the program’s eligibility requirements.

Exelixis Access Services Patient Assistance Program

This program provides Cometriq free of charge to patients who do not have insurance coverage and who meet eligibility requirements.

Lenvima (lenvatinib)

Drug company: Eisai
866-613-4724

Lenvima is a kinase inhibitor and single agent used for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer.

Eisai offers 2 financial assistance programs for patients using Lenvima:

Lenvima $0 Co-pay Program

Privately insured patients may be eligible for this program, which offers a $0 copay for each prescription, with a $40,000 annual limit.

Eisai Assistance Program

This program provides Lenvima at no cost to financially needy patients who meet program eligibility criteria.

Nexavar (sorafenib) Tablets

Drug company: Bayer
866-639-2827

Nexavar is a kinase inhibitor used for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma, refractory to radioactive iodine treatment.

Bayer’s Resources for Expert Assistance and Care Helpline (REACH) offers 2 financial assistance programs for patients using Nexavar:

Nexavar $0 Co-Pay Program

With this program, patients with private insurance pay a $0 copay for Nexavar, and the program pays up to $25,000, with no monthly maximum.

REACH Patient Assistance Program

Uninsured or underinsured patients who are prescribed Nexavar should contact the REACH services counselor to possibly qualify for free medication.

Synthroid (levothyroxine sodium tablets, USP)

Drug company: AbbVie
800-222-6885

Synthroid is used as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.

AbbVie offers 1 financial assistance program for patients using Synthroid:

AbbVie Patient Assistance Foundation

Patients without insurance and with limited income may qualify to receive free Synthroid. Patients enrolled in Medicare Part D or another insurance program may be eligible for assistance on an exception basis.

Thyrogen (thyrotropin alfa)

Drug company: Sanofi Genzyme
888-497-6436

Thyrogen is used as an adjunctive diagnostic tool for testing with or without radioiodine imaging in the follow-up of patients with well-differentiated thyroid cancer who have previously undergone thyroidectomy. Thyrogen is also used as an adjunctive treatment in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer.

ThyrogenONE offers 2 financial assistance programs for patients using Thyrogen:

Thyrogen Co-Pay Assistance Program

Privately insured patients with out-of-pocket costs exceeding $100 for each Thyrogen kit may be eligible for assistance. This program requires patients to pay $100 of their out-of-pocket costs, and Sanofi Genzyme will cover any additional out-of-pocket costs, up to $1,000 per calendar year.

Thyrogen Patient Assistance Program

Patients who are uninsured or underinsured may be eligible to receive up to 2 kits of Thyrogen per calendar year.

Tirosint (levothyroxine sodium)

Drug company: Akrimax
908-372-0506

Tirosint capsules work as pituitary thyrotropin-stimulating hormone suppression and are used for the treatment of patients with thyrotropin-dependent well-differentiated thyroid cancer, as an adjunct to surgery and radioiodine therapy.

Akrimax offers 2 financial assistance programs for patients using Tirosint:

Tirosint Savings Card

With this savings card, patients are responsible for the first $35 and will receive up to $35 off their out-of-pocket expenses. Insured and cash-paying patients are eligible for the savings card. Medicare and Medicaid patients are not eligible for the program.

Akrimax Patient Assistance Program

Patients who meet Akrimax’s income guidelines may be eligible to receive Tirosint for free. Qualifying patients are eligible for free medication for 1 year and must then reapply to the program.

Table. Drugs Prescribed for Thyroid Cancer

  • Drug name (generic name)
  • Drug company
  • Indication
  • Patient support services
    Drug name (generic name)
  • Armour Thyroid (thyroid tablets, USP)
  • Drug company
  • Allergan
  • Indication
  • Thyroid cancer
  • Patient support services
  • Allergan Patient Assistance Program
    844-424-6727



    Drug name (generic name)
  • Lenvima (lenvatinib)
  • Drug company
  • Eisai
  • Indication
  • Locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer
  • Patient support services
  • Lenvima $0 Co-pay Program
    866-613-4724

    Eisai Assistance Program
    866-613-4724

    Drug name (generic name)
  • Nexavar (sorafenib) Tablets
  • Drug company
  • Bayer
  • Indication
  • Locally recurrent or metastatic, progressive, differentiated thyroid cancer, refractory to radioactive iodine treatment
  • Patient support services
  • Nexavar $0 Co-Pay Program
    866-639-2827

    REACH Patient Assistance Program
    866-639-2827

    Drug name (generic name)
  • Synthroid (levothyroxine sodium tablets, USP)
  • Drug company
  • AbbVie
  • Indication
  • Thyrotropin-dependent well-differentiated thyroid cancer, as adjunct to surgery and radioiodine therapy
  • Patient support services
  • AbbVie Patient Assistance Foundation
    800-222-6885

    Drug name (generic name)
  • Thyrogen (thyrotropin alfa)
  • Drug company
  • Sanofi Genzyme
  • Indication
  • Adjunctive diagnostic tool for testing for well-differentiated thyroid cancer with previous thyroidectomy

    Adjunct treatment for radioiodine ablation of thyroid tissue remnants, after thyroidectomy for well-differentiated thyroid cancer
  • Patient support services
  • Thyrogen Co-Pay Assistance Program
    888-497-6436

    Thyrogen Patient Assistance Program
    888-497-6436

    Drug name (generic name)
  • Tirosint (levothyroxine sodium)
  • Drug company
  • Akrimax
  • Indication
  • Thyrotropin-dependent well-differentiated thyroid cancer, as an adjunct to surgery and radioiodine therapy
  • Patient support services
  • Tirosint Savings Card
    908-372-0506

    Akrimax Patient Assistance Program
    855-856-6915

Last modified: April 16, 2018

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country